Elon Musk's Neuralink plans a brain speech trial in October

Neuralink plans an October clinical trial for its brain implant to convert thoughts to text for speech-impaired patients, operating under FDA exemption. This could significantly improve communication efficiency. While potentially transformative for severely impaired individuals, concerns arise from the company's vision of implants for healthy people within 3-4 years, enabling thought-speed AI interactions. Questions remain about balancing medical benefits against broader implications for humanity, considering current technology-related societal issues and Musk's majority ownership.